Calithera Completes Enrollment in Mid-Stage RCC Study

October 9, 2019

PTC Therapeutics Establishes Strategic Collaboration with Aldevron

October 9, 2019

PTC Therapeutics Announces New Real-World Analysis Demonstrating Translarna™ Slows Disease Progression in Patients with Duchenne Muscular Dystrophy

October 9, 2019

Verastem Announces Dosing of First Patient in Japanese Bridging Study

October 9, 2019

Calithera Biosciences Completes Patient Enrollment in Randomized CANTATA Trial of Telaglenastat and Cabozantinib in Advanced Renal Cell Carcinoma

October 3, 2019

Dana-Farber Study Confirms Accuracy of GRAIL’s Blood Test for Cancer

October 1, 2019